Maravai Lifesciences Holdings (MRVI) Goodwill (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Goodwill of $129.4 million for Q1 2026, up 3706.74% year-over-year from $3.4 million in Q1 2025, and little changed quarter-over-quarter from $129.4 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Goodwill (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Goodwill history runs 7 years deep, the most recent figure standing at $129.4 million for Q1 2026.
- In Q1 2026, Goodwill rose 3706.74% year-over-year to $129.4 million; the TTM figure through Mar 2026 stood at $129.4 million (up 3706.74% YoY), while the FY2025 annual figure was $129.4 million, down 19.05% from the prior year.
- Goodwill for Q1 2026 stood at $129.4 million, roughly flat from $129.4 million in the prior quarter.
- The five-year high for Goodwill was $326.6 million in Q1 2023, with the low at $3.4 million in Q1 2025.
- The 5-year median for Goodwill is $283.5 million (2022), against an average of $223.0 million.
- The sharpest annual moves came in 2025 and 2026: Goodwill tumbled 98.96% in 2025, then surged 3706.74% in 2026.
- Maravai Lifesciences Holdings' Goodwill stood at $283.7 million in 2022, then advanced by 14.92% to $326.0 million in 2023, then tumbled by 50.96% to $159.9 million in 2024, then decreased by 19.05% to $129.4 million in 2025, then changed by 0.0% to $129.4 million in 2026.
- Business Quant data shows MRVI's Goodwill at $129.4 million in Q1 2026, $129.4 million in Q4 2025, and $129.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 129.43 Mn |
| Mar 31, 2026 | 129.43 Mn |
| Dec 31, 2025 | 129.43 Mn |
| Sep 30, 2025 | 129.43 Mn |
| Jun 30, 2025 | 129.43 Mn |
| Mar 31, 2025 | 3.40 Mn |
| Dec 31, 2024 | 159.88 Mn |
| Sep 30, 2024 | 171.79 Mn |
| Jun 30, 2024 | 326.03 Mn |
| Mar 31, 2024 | 326.03 Mn |
| Dec 31, 2023 | 326.03 Mn |
| Sep 30, 2023 | 326.03 Mn |
| Jun 30, 2023 | 326.50 Mn |
| Mar 31, 2023 | 326.57 Mn |
| Dec 31, 2022 | 283.70 Mn |
| Sep 30, 2022 | 283.54 Mn |
| Jun 30, 2022 | 283.50 Mn |
| Mar 31, 2022 | 130.80 Mn |
| Dec 31, 2021 | 152.77 Mn |
| Sep 30, 2021 | 152.80 Mn |